Developments

2012

AMAR International JV Prime Managing Member Awarded CIO-SP3 Contract. Reston, VA. July 9, 2012.  AMAR International, Inc. (AMAR) is one of the JV partnering companies to have been awarded a Chief Information Office – Solutions and Partners 3 (CIO-SP3) contract administered by the National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC). Contract holders have developed innovative and secure solutions for agencies across the federal government and initiatives as diverse as Cloud Computing, Cyber Defense and Health IT.

2011

AMAR International Appoints Mr. Daniel Himelfarb, MBA to the Business Advisory Board. Reston, VA. November 1, 2011. AMAR International, Inc. (AMAR) has appointed Mr. Daniel Himelfarb, MBA, as a Business Advisor to the company for special market assessments, product and company evaluations, including market research, new product and market opportunity assessments.

AMAR International Appoints Dr. James A. Rodger as Senior Technical Advisor. Reston, VA. September 11, 2011. AMAR International, Inc. (AMAR) has appointed Dr. James A. Rodger, as Senior Technical Advisor for Information Technology and Project Management to work with the company on various programs.

AMAR International Appoints COL Dr. Stanley John Whidden, MD, Ph.D. as Senior Medical Officer. Reston, VA. May 3, 2011. AMAR International, Inc. (AMAR) has appointed Dr. Stanley J. Whidden, MD, Ph.D., as Senior Medical Officer to work with the company on various programs on biomedical sciences, including biodefense.

AMAR International Appoints Dr. Lawrence Ernst as Senior Statistician. Reston, VA. January 2, 2011. AMAR International, Inc. (AMAR) has appointed Dr. Lawrence Ernst as Senior Statistician to work with the company on various programs related to statistical and mathematical analyses.

2010

AMAR International Appoints Dr. Tosca E. Kinchelow-Schmidt as Senior Medical Officer. Reston, VA. June 7, 2010. AMAR International, Inc. (AMAR) has appointed Dr. Tosca E. Kinchelow-Schmidt, MD, as Senior Medical Officer to work with the company on various programs related to infectious diseases and vaccine product development.

AMAR International Appoints Dr. David Edward Weng as Senior Medical Officer. Reston, VA. May 17, 2010. AMAR International, Inc. (AMAR) has appointed David Edward Weng, MD, Ph.D., as Senior Medical Officer to work with the company on various programs related to medical oncology and product development.“We are very pleased to have Dr. David Weng join our distinguished group of AMAR senior professionals who are national and international opinion leaders in their areas of expertise”, commented Dr. John Prakash, Chief Scientific Officer and Senior Vice President at AMAR.

2009

LAXAI enters partnership with AMAR. Reston, VA. October 26, 2009. LAXAI, a leading Contract Research Organization based in U.S. and India providing integrated services to the global life science market across the Drug Discovery and Development spectrum, has entered into a strategic partnership with the Biomedical Division of AMAR International (AMAR).

AMAR International Appoints Dr. Bing Zhang as Senior Fellow. Reston, VA. August 5, 2009. AMAR International, Inc. (AMAR) has appointed Bing Zhang, Ph.D., as an AMAR Senior Fellow to work with the company senior management on various programs related to statistical analyses, data management, and other analytical science projects.

AMAR International Appoints Mr. Chris Campbell as Senior Fellow. Reston, VA. August 4, 2009. AMAR International, Inc. (AMAR) has appointed Mr. Chris Campbell, as an AMAR Senior Fellow to work with the company senior management on strategic healthcare management programs.

AMAR International Appoints Dr. Gary Kreps as Senior Fellow. Reston, VA. July 23, 2009. AMAR International, Inc. (AMAR) has appointed Gary Kreps, Ph.D., as AMAR Senior Fellow to work with the company senior management on various programs related to health and risk communication, healthcare information technology, and other healthcare programs.

AMAR International Appoints Dr. Christine Lawless as Senior Fellow. Reston, VA. July 21, 2009. AMAR International, Inc. (AMAR) has appointed Christine Lawless, MD, MBA, ABCL, FACC, FACSM, as AMAR Senior Fellow to work with the company senior management on various programs.

AMAR International Appoints Dr. David Baron as Senior Fellow. Reston, VA. July 7, 2009. AMAR International, Inc. (AMAR) has appointed David Baron, MSEd, DO, as AMAR Senior Fellow to work with the company senior management on various programs related to substance abuse, treatment of drug abuse and other behavioral sciences programs.

2008

George Mason University | Madison Enterprise Center Press Release November 2008. AMAR International to Work on a New US Government Contract with IBT for Development of a Vaccine against Ebola and Marburg Viruses. Fairfax, VA, November 7, 2008. – AMAR International, Inc. (AMAR), a biomedical program management company specializing in development of biomedical products, biodefense programs, clinical research, data management, and information technology is partnering with Maryland based Integrated BioTherapeutics Inc. (IBT), a biotechnology company focused on development of medical countermeasures for biodefense and emerging infectious diseases, on a newly awarded contract from the United States Government. The contract, awarded to IBT and team, is for a multiyear program for advanced development of a vaccine to protect against Ebola and Marburg viruses from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH).

AMAR International to Work on a New US Government Contract with IBT for Development of a Vaccine against Ebola and Marburg Viruses. Fairfax, VA, November 7, 2008. – AMAR International, Inc. (AMAR), a biomedical program management company specializing in development of biomedical products, biodefense programs, clinical research, data management, and information technology is partnering with Maryland based Integrated BioTherapeutics Inc. (IBT), a biotechnology company focused on development of medical countermeasures for biodefense and emerging infectious diseases, on a newly awarded contract from the United States Government. The contract, awarded to IBT and team, is for a multiyear program for advanced development of a vaccine to protect against Ebola and Marburg viruses from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH).

AMAR International Awarded US Government – NIH Contract for NIDA CJ-DATS 2 Program. Fairfax, VA. October 16, 2008. AMAR International, Inc. (AMAR), a healthcare program management company specializing in development of biomedical products, clinical research, data management, and information technology has received a large multi-year contract (five base years plus options) from the United States Government’s National Institutes of Health (NIH) – National Institute on Drug Abuse (NIDA) to provide logistical support for its Criminal Justice Drug Abuse Treatment Studies 2 (CJ-DATS 2) program.

First Diversity Alliance For Science Conference has announced that Dr. Gyan (John) Prakash, chief scientific officer and senior vice president of AMAR International, Inc., is the keynote speaker for the organization’s inaugural networking conference and expo scheduled for May 19-20 at the Westin Governor Morris in Morristown, N.J.

http://www.clickpress.com/releases/Detailed/72829005cp.shtml

http://www.pr.com/press-release/85187

http://www.prlog.org/10071353-diversity-alliance-for-science-conference-names-dr-gyan-prakash-as-keynote-speaker.pdf

http://trade-professional-services.dbusinessnews.com/shownews.php?newsid=159005&type_news=past

Dr. John Prakash appointed on GAIBP Board of Directors
http://www.btbits.com/gaibp/

2007

FOR IMMEDIATE RELEASE
Contact: AMAR International, Inc. (www.amar-international.com)
Info@amar-international.com

AMAR Expands Information Technology Capabilities Through Strategic Partnership with Altum, Inc.
Fairfax, VA. October 30, 2007 – AMAR International (www.amar-international.com), a biomedical program management and engineering services company that specializes in the management of clinical and scientific research, and regulatory management for drugs and biologics development has expanded its offering by signing a strategic partnership with Altum, Inc., a leader in providing information technology solutions to the biomedical research community.

Dr. Savita Prakash, President of AMAR International, stated, “AMAR is proud to add Altum as a strategic partner. Altum’s experience in developing information technology solutions in the biomedical area will allow AMAR to augment its existing scientific and regulatory management capabilities with a solid foundation of technology capabilities.”

“We have over 30 clients in the biomedical research industry. This partnership with AMAR enables Altum not only the ability to offer clinical, scientific, and regulatory expertise to our clients, but also ensures that our solutions are developed to meet the unique needs of the industry” said Altum’s Vice President, Mr. Rakesh Nayak.

About AMAR International

American Medical-Marketing and Analytical Research (AMAR) is a biomedical and engineering services company. The company is dedicated to offering the right solution to federal agencies, pharmaceutical/ biotechnology companies, financial institutions/investment banking companies, and clinical research organizations. AMAR’s approach is object oriented, giving our clients focused knowledge and strategic tools to accomplish their project goals. Our medical, scientific, engineering, and marketing professionals are highly specialized.

AMAR International is SBA certified, SDB, 8(a), WOB Company. It was established in 1994, and incorporated in 1999. AMAR’s main office is located at Fairfax Innovation Center, in Fairfax, Virginia. The office is in close proximity to numerous federal agencies in the Washington D.C. metro area and located about 20 minutes from Dulles International Airport.

About Altum, Inc.

Altum provides industry-leading Grants Management, Knowledge Management, and Performance Management solutions. Since 1997, Altum has provided innovative software products and services to philanthropic and government organizations, with a special emphasis on biomedical research. Altum’s products include proposalCENTRAL, an e-grantmaking website shared by many government, non-profit, and private grant-making organizations; Easygrants®, a highly configurable E-grants solution that meets the unique needs of grantmaking organizations; and Infor MPC, the industry leading performance management solution ranked #1 by Ventana Research in 2005, 2006 and 2007.

Founded in 1997, Altum is a privately held corporation headquartered in Reston, VA, just outside Washington, D.C.

Archive